Cormorant Asset Management
Hedge Fund
Investment firm focused on innovative biotech, MedTech and life science companies in both public and private markets.
Boston, United States · 59+ investments · 2 portfolio companies
Early Stage
Growth
Late Stage
Biotech
Healthcare
Life Sciences
- Headquarters
- Boston, United States
- Founded
- 2013
- Website
- cormorant-capital.com
- AUM
- $3.0B
- Portfolio Companies
- 2
- Total Investments
- 59
- Last Investment
- Feb 2026
- Geographic Focus
- United States
Investment Thesis
We invest in real estate transactions, facilitating growth for operators and...
Cormorant Asset Management is a Hedge Fund firm based in Boston, United States. It has made 59 investments in Biotech and Healthcare, including GC Therapeutics and Erasca.
Portfolio2
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.